Core Viewpoint - Dentsply International (XRAY) is currently viewed as a better value opportunity compared to The Cooper Companies (COO) based on various financial metrics and rankings [1]. Valuation Metrics - Dentsply International has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while The Cooper Companies has a Zacks Rank of 4 (Sell) [3]. - The forward P/E ratio for XRAY is 8.88, significantly lower than COO's forward P/E of 20.54, suggesting XRAY is undervalued [5]. - XRAY's PEG ratio is 1.20, compared to COO's PEG ratio of 2.06, indicating XRAY has a more favorable earnings growth outlook relative to its price [5]. - The P/B ratio for XRAY is 1.65, while COO's P/B ratio is 2.01, further supporting the argument that XRAY is a better value investment [6]. - Overall, XRAY has earned a Value grade of A, whereas COO has a Value grade of C, highlighting XRAY's superior valuation metrics [6]. Conclusion - Based on the solid earnings outlook and favorable valuation figures, Dentsply International is considered the superior value option compared to The Cooper Companies at this time [7].

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they ...

Dentsply Sirona Inc. XRAY stock surged about 15% Thursday, and was on track for the biggest single-day advance since 2019 after posting earnings that topped estimates.The company reported first-quarter 2025 adjusted earnings per share of 43 cents, beating the street view of 30 cents.Dentsply Sirona reported sales of $879 million on Thursday, beating the consensus of $854.75 million.First quarter net sales decreased 7.7% (organic sales decreased 4.4%) compared to the first quarter of 2024. Foreign currency c ...

DENTSPLY SIRONA Inc. (XRAY) reported first-quarter 2025 adjusted earnings per share (EPS) of 43 cents, up by a penny year over year. The bottom line surpassed the Zacks Consensus Estimate by 48.3%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)GAAP EPS in the quarter under review was 10 cents, also up by a penny year over year.DENTSPLY SIRONA’s RevenuesRevenues grossed $879 million in the reported quarter, down 7.7% year over year. However, the metric beat the Zacks Consensus Esti ...

Dentsply International (XRAY) reported $879 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 7.8%. EPS of $0.43 for the same period compares to $0.42 a year ago.The reported revenue represents a surprise of +3.22% over the Zacks Consensus Estimate of $851.55 million. With the consensus EPS estimate being $0.29, the EPS surprise was +48.28%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to ...

DENTSPLY SIRONA (XRAY) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Andrea Daley - Vice President, Investor RelationsSimon Campion - CEO, President & DirectorJonathan Block - Managing Director Conference Call Participants Elizabeth Anderson - Senior Managing Director & Research AnalystMichael Cherny - Senior Managing Director & Senior Research AnalystDylan Finley - Equity Research AnalystDavid Saxon - Senior AnalystSimran Kaur - Equity Research AnalystJeffrey Johnson - Managing Direct ...

DENTSPLY SIRONA (XRAY) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Speaker0 Please be advised that today's conference is being recorded. I would now like to hand the call over to Andrea Daley, Vice President of Investor Relations. Please go ahead. Speaker1 Thank you, operator, and good morning, everyone. Welcome to the Dentsply Thirona first quarter twenty twenty five earnings call. Joining me for today's call is Simon Campion, Chief Executive Officer and Rich Rosenzweig, Executive Vice President, Corpor ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer incorporation ...

Dentsply International (XRAY) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.42 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 48.28%. A quarter ago, it was expected that this dental products manufacturer would post earnings of $0.43 per share when it actually produced earnings of $0.26, delivering a surprise of -39.53%.Over the las ...

Dentsply Sirona Reports First Quarter 2025 Results Charlotte, N.C., May 8, 2025 - DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the first quarter of 2025. First quarter net sales of $879 million decreased (7.7%) (organic sales decreased (4.4%)) compared to the first quarter of 2024. Foreign currency changes negatively impacted first quarter 2025 net sales by approximately ($30) million. Net income was $20 million, or $0.10 per share, compa ...